66 results
8-K
EX-1.1
CRNX
Crinetics Pharmaceuticals Inc
21 Jun 24
Other Events
5:24pm
diligence review satisfactory to it in its reasonable judgment, and to the continuing satisfaction (or waiver by each of the Agents in its sole discretion
8-K
EX-5.1
CRNX
Crinetics Pharmaceuticals Inc
21 Jun 24
Other Events
5:24pm
and Restated Bylaws and originals or copies, certified or otherwise identified to our satisfaction, of such agreements, instruments, documents
S-3ASR
EX-5.1
CRNX
Crinetics Pharmaceuticals Inc
21 Jun 24
Automatic shelf registration
4:45pm
or copies, certified or otherwise identified to our satisfaction, of such agreements, instruments, documents, certificates and records as we have
S-3ASR
EX-5.1
CRNX
Crinetics Pharmaceuticals Inc
19 Mar 24
Automatic shelf registration
4:05pm
Statement.
As counsel for the Company, we have examined originals or copies, certified or otherwise identified to our satisfaction, of the Registration
8-K
EX-99.1
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
, before deducting any offering-related expenses. The private placement is expected to close on or about March 1, 2024, subject to the satisfaction … , including statements regarding Crinetics’ expectations of market conditions and the satisfaction of customary closing conditions related to the private
8-K
EX-10.1
eczwhyjzmknbb tn8
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
S-8
EX-5.1
746bqd zifkg
28 Feb 24
Registration of securities for employees
6:04pm
8-K
EX-99.2
6vdz5s0tw
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
8-K
EX-99.1
3e1ophwyt4cs
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
8-K
dcpdeo
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
8-K
EX-1.1
3u5ok
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
424B5
yjc4iydkiqw1 2j6shfg
13 Sep 23
Prospectus supplement for primary offering
5:19pm
424B5
cs53mjw
11 Sep 23
Prospectus supplement for primary offering
4:09pm
8-K
EX-99.1
cntiyl1 r86
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm
8-K
12b86uivdysm nerx75
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm
8-K
EX-1.1
ofq02btvs1 qgt0dhza
13 Apr 22
Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
4:26pm